"Chr. Hansen also achieved a 19% increase in EBIT. The organic growth (excluding carmine price effect) of 9% in Q3 was slightly better than expected," says CEO Lars Frederiksen. The companies’ revenue was €514 million ($646 million), up 8% compared to the first nine months of 2010/11.
